8-KThe WireRoutine
Shareholder Vote
Filed Jun 15, 2022 · 4y ago · Accession 0000950170-22-011646
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Janux Therapeutics, Inc.
- Ticker
- JANX
- CIK
- 1817713
- Form type
- 8-K
- Filing date
- Jun 15, 2022
- Report date
- Jun 14, 2022
- Document
- janx-20220614.htm
- Size
- 198 KB